Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CABR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caring Brands, Inc. filings document the company's securities registration, capital structure, governance changes, and material events as a Nasdaq-listed wellness consumer products issuer. Its S-1 registration materials describe common stock offerings, business disclosures, risk factors, financial statements, and the company's OTC and cosmetic product focus.
Recent 8-K filings cover Nasdaq continued-listing compliance, amendments to shareholder-meeting quorum requirements, executive finance-function changes, and financing transactions involving Series A Convertible Preferred Stock, common warrants, and insider share redemptions. Other event disclosures record patent-related updates for the Hair Enzyme Booster product and related intellectual property matters.
Caring Brands, Inc. files its annual report describing a wellness consumer products business that remains in early stages with minimal revenue and significant losses. The company reports a net loss of $6,278,191 for the year ended December 31, 2025, following a net loss of $1,517,431 for 2024, and its auditors raise substantial doubt about its ability to continue as a going concern.
The business centers on over-the-counter and cosmetic products such as Photocil for psoriasis and vitiligo, the Hair Enzyme Booster (JW-700) to enhance minoxidil, and CB-101 for eczema, supported by multiple clinical trials and patents. Licensing agreements with partners including Taisho in Japan and Cosmofix/San Pellegrino in India and other territories underpin its commercialization strategy, while most products use GRASE ingredients under OTC or cosmetic frameworks.
The company is authorized to issue 100,000,000 common shares at $0.001 par value and reports 13,336,925 shares outstanding as of June 30, 2025 and 12,341,506 shares outstanding as of March 30, 2026. Caring Brands qualifies as an emerging growth company and smaller reporting company, using scaled disclosure and extended transition for new accounting standards, and highlights extensive regulatory, competitive, funding, and execution risks.
Caring Brands, Inc. reported two governance changes. The Board amended the company’s bylaws so that stockholders holding thirty-three and one-third percent (33 1/3%) of outstanding capital stock entitled to vote now constitute a quorum for stockholder meetings, instead of a majority. The Board also appointed founder and Chairman Brian John, age 56, to serve as Interim Chief Financial Officer and to act as principal financial officer and principal accounting officer, effective March 30, 2026. As of this filing, his existing compensation arrangements remain unchanged in connection with this interim appointment.
Caring Brands, Inc. Chief Executive Officer Dr. Glynn Wilson reported a disposition of 1,500,000 shares of common stock back to the company. The shares were redeemed at approximately $0.50 per share under a Share Redemption Agreement signed on March 19, 2026.
After this issuer redemption, Dr. Wilson beneficially owns 500,000 shares of common stock and 172,592 restricted stock units, none of which have vested. He therefore continues to hold a meaningful equity stake that aligns his interests with other shareholders.
Caring Brands, Inc. director John Brian reported a large share redemption transaction. He disposed of 1,250,000 shares of Common Stock at approximately $1.00 per share in a redemption by the company under a Share Redemption Agreement signed on March 19, 2026. After this disposition to the issuer, he directly holds 750,000 shares of Caring Brands common stock.
Caring Brands, Inc. entered into a $3.6 million private investment in public equity, issuing 3,789.74 shares of Series A Convertible Preferred Stock at $950 per share with a stated value of $1,000 and an 8% dividend. The preferred stock is convertible into common shares at $0.40 and is paired with 9,473,685 common warrants, also exercisable at $0.40 for five years, all subject to beneficial ownership limits and a 19.99% cap without shareholder approval.
The company plans to use $3.075 million of the proceeds to repurchase 6,250,000 common shares from insiders, reducing common shares outstanding from 14,761,925 to 8,511,925, with the balance for general corporate and working capital needs. The investor also obtained an option to invest up to an additional $4.0 million on similar terms and received a 12‑month right of first refusal on future financings, while the company agreed to register the resale of the underlying shares.
Caring Brands, Inc. reported that it has been issued two new United States patents. These patents cover proprietary methods and compositions that enhance enzymatic activity in hair follicles. Management explains that this intellectual property further strengthens protection around its Hair Enzyme Booster product and related technologies, potentially reinforcing its competitive position in hair-focused treatments.
Caring Brands, Inc. reported that its Chief Financial Officer, Tyler Moore, resigned from his position effective after notifying the company on January 5, 2026. The company states that his resignation was not due to any disagreement regarding its operations, policies, or practices, which signals this is characterized as an orderly leadership change rather than a dispute.
Caring Brands has begun a search to identify a new Chief Financial Officer and expects to appoint a successor in the near term. Until a replacement is named, the company plans to handle its financial and reporting responsibilities through its existing management team, indicating continuity of core finance functions during the transition.
Caring Brands, Inc. reported that director Hector W. Alila received a grant of stock options to purchase 25,000 shares of common stock at an exercise price of $1.13 per share on December 11, 2025.
The options vested immediately on the grant date and are scheduled to expire on December 11, 2030, leaving 25,000 derivative securities beneficially owned directly by the reporting person after the transaction. The grant was approved by the company’s board of directors under its equity incentive plan following a recommendation from the compensation committee.
Caring Brands, Inc. reported an insider equity award involving a director who is also a 10% owner. On December 11, 2025, the board, following a recommendation from the compensation committee, approved a grant of 100,000 stock options under the company’s equity incentive plan, with an exercise price of $1.243 per share and no cost to acquire the options themselves.
The options are scheduled to fully vest on June 11, 2026, provided the reporting person continues to serve the company, and they are set to expire on December 11, 2030. After this transaction, the reporting person beneficially owns 100,000 stock options and also holds 2,000,000 shares of Caring Brands common stock.
Caring Brands, Inc. director Christopher Melton reported receiving a stock option grant from the company. On December 11, 2025, the board of directors, following a recommendation from the compensation committee, approved an option for Melton to buy 25,000 shares of common stock at an exercise price of $1.13 per share under the company’s equity incentive plan.
The options vested immediately on December 11, 2025 and expire on December 11, 2030. Following this grant, Melton beneficially owns 25,000 stock options directly.